Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript
FDA review nears completion as reimbursement rates support commercial launch.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Confidence plunges in blow to Burnham: Households most gloomy since 2023 amid fears for jobs
Workers are growing anxious about job security, the findings from S&P Global's UK consumer sentiment index suggested.
Granite REIT Declares Distribution for August 2026
TORONTO — Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN) announced today that its board of trustees has declared a distribution of CDN $0.2958 per unit for the month of August 2026.
PIMCO Canada Corp. Announces Monthly Distributions for PIMCO Canada Exchange Traded Series
Not for distribution to United States newswire services or for dissemination in the United States TORONTO — PIMCO Canada Corp.
Viant (DSP) Q2 2026 Earnings Call Transcript
CTV revenue jumped 34% as advertisers adopted the company's AI intelligence layer.
James River Group (JRVR) Q2 2026 Earnings Call Transcript
E&S profitability improved as management shifts toward smaller accounts and specialty lines.
Test Your ETF Knowledge In Our IQ Test
Bloomberg's Joel Weber puts Scarlet Fu, James Seyffart, and Todd Sohn, ETF strategist at Baird Strategas, to the test on "Bloomberg ETF IQ" in this week's edition of "IQ Test." (Source: Bloomberg)